FDA Adverse Event Malfunction Summary report: N

TRILOGY EV300, USA

MDR report key: 22042623 · Received May 19, 2025

Report

Report Number
2518422-2025-105818
Event Type
Malfunction
Date Received
May 19, 2025
Date of Event
May 14, 2025
Report Date
November 5, 2025
Manufacturer
RESPIRONICS, INC.
Product Code
CBK
UDI-DI
00606959052017
PMA / PMN Number
K181166
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

PREVIOUSLY REPORTED BY THE MANUFACTURER: PREVIOUSLY REPORT TO THE MANUFACTURER: A TRILOGY EV300 WAS SENT TO A THIRD-PARTY SERVICE CENTER FOR EVALUATION. THERE WAS NO HARM OR INJURY REPORTED. THE DEVICE WAS NOT IN PATIENT USE. DURING THE EVALUATION OF THE DEVICE AT THE SERVICE CENTER, THE DEVICE UNIT FAILED PRE-TESTING, UNIT FAILED SYSTEM SETUP TEST (ACTIVE EXHALATION VERIFICATION: S(+) P(+): PILOT: READING FAILED). THE TECHNICIAN RECOMMENDED REPLACING THE TRILOGY EVO 3-WAY SOLENOID, PROPORTIONAL VALVE (AECM) AND OXYGEN BLENDING MODULE (OBM) TO ADDRESS THE ISSUE. THE REPAIRS ARE PENDING THE CUSTOMERS APPROVAL. FCO FOLLOW-UP REPAIR TO BE HANDLED BY CARROT MEDICAL. A SUPPLEMENT REPORT WILL BE FILED IF NEW INFORMATION BECOMES AVAILABLE. INFORMATION REPORTED IN DUPLICATE RA 320523417 PR 773045. A TRILOGY EV300 VENTILATOR WAS RETURNED TO A THIRD-PARTY SERVICE CENTER FOR ROUTINE PREVENTATIVE MAINTENANCE. THERE WAS NO ALLEGATION OF DEVICE MALFUNCTION. THE DEVICE WAS NOT IN PATIENT USE. DURING THE EVALUATION OF THE DEVICE AT THE SERVICE CENTER, AFTER REPLACING THE PROPORTIONAL VALVE (AECM) AND 3 WAY SOLENOID VALVE, THE UNIT FAILED THE SENSOR DRIFT VERIFICATION TEST. THIS WAS NOT AN INITIAL FAILURE AND OCCURRED AFTER REPAIRS WERE PERFORMED ON THE DEVICE. PROPORTIONAL VALVE (AECM) AND 3 WAY SOLENOID VALVE WERE REPLACED, ALONG WITH THE FLOW SENSOR AS PART OF FCO8. EV300 SYSTEM BOARD WAS REPLACED TO ADDRESS THE SENSOR DRIFT VERIFICATION TEST FAILURE. PREVIOUSLY REPORTED: THE FAILED PROPORTIONAL VALVE (AECM) AND 3 WAY SOLENOID VALVE WERE RECEIVED AT THE PHILIPS PRODUCT INVESTIGATION LAB FOR FURTHER INVESTIGATION. ERROR CODES WERE NOTED IN THE EVENT LOG. BOX H CODING WAS UPDATED. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE. NEW INFORMATION/LINV: THE PROPORTIONAL VALVE AND SOLENOID VALVE WERE RETURNED TO RIQL FOR AN ACTIVE EXHALATION VERIFICATION TEST FAILURE AT SERVICE. THIS FAILURE IS BEING FURTHER INVESTIGATED BY THE MANUFACTURER. NO FURTHER EVALUATION OF THIS PART IS REQUIRED AT THIS TIME. THE TUBING WAS RETURNED TO RIQL FOR THE FAILURE OF A SENSOR DRIFT OR AECM TEST FAILURE AT SERVICE. THE TUBING WOULD ONLY FAIL DUE TO PHYSICAL DAMAGE OR CLOGGING DUE TO CONTAMINATION. NO FURTHER INVESTIGATION OF THE TUBING IS REQUIRED AT THIS TIME. THE TRILOGY EVO SYSTEM BOARD WAS RETURNED TO RIQL WITH THE ALLEGATION OF A SENSOR DRIFT TEST FAILURE AT SERVICE. THE PRODUCT INVESTIGATION LAB (PIL) WAS ABLE TO CONFIRM A FAILURE OF THE SYSTEM BOARD. THE PRODUCT INVESTIGATION LAB (PIL) VISUALLY INSPECTED THE TRILOGY EVO SYSTEM BOARD FOR VISUAL DEFECTS AND FOUND THAT THE MT7 SENSOR MAY HAVE BEEN PREVIOUSLY DAMAGED AND APPEARS TO HAVE BEEN ALTERED WITH SOME TYPE OF ADHESIVE. PIL SUSPECTS THAT THE TAMPERING OF THE SENSOR CAUSED THE SENSOR DRIFT FAILURE AT SERVICE. THE TRILOGY EVO SYSTEM PCA HAS BEEN SCRAPPED.

Additional Manufacturer Narrative · 0

PREVIOUSLY REPORT TO THE MANUFACTURER: A TRILOGY EV300 WAS SENT TO A THIRD-PARTY SERVICE CENTER FOR EVALUATION. THERE WAS NO HARM OR INJURY REPORTED. THE DEVICE WAS NOT IN PATIENT USE. DURING THE EVALUATION OF THE DEVICE AT THE SERVICE CENTER, THE DEVICE UNIT FAILED PRE-TESTING, UNIT FAILED SYSTEM SETUP TEST (ACTIVE EXHALATION VERIFICATION: S(+) P(+): PILOT: READING FAILED). THE TECHNICIAN RECOMMENDED REPLACING THE TRILOGY EVO 3-WAY SOLENOID, PROPORTIONAL VALVE (AECM) AND OXYGEN BLENDING MODULE (OBM) TO ADDRESS THE ISSUE. THE REPAIRS ARE PENDING THE CUSTOMERS APPROVAL. FCO FOLLOW-UP REPAIR TO BE HANDLED BY CARROT MEDICAL. A SUPPLEMENT REPORT WILL BE FILED IF NEW INFORMATION BECOMES AVAILABLE. INFORMATION REPORTED IN DUPLICATE RA 320523417 PR 773045. A TRILOGY EV300 VENTILATOR WAS RETURNED TO A THIRD-PARTY SERVICE CENTER FOR ROUTINE PREVENTATIVE MAINTENANCE. THERE WAS NO ALLEGATION OF DEVICE MALFUNCTION. THE DEVICE WAS NOT IN PATIENT USE. DURING THE EVALUATION OF THE DEVICE AT THE SERVICE CENTER, AFTER REPLACING THE PROPORTIONAL VALVE (AECM) AND 3 WAY SOLENOID VALVE, THE UNIT FAILED THE SENSOR DRIFT VERIFICATION TEST. THIS WAS NOT AN INITIAL FAILURE AND OCCURRED AFTER REPAIRS WERE PERFORMED ON THE DEVICE. PROPORTIONAL VALVE (AECM) AND 3 WAY SOLENOID VALVE WERE REPLACED, ALONG WITH THE FLOW SENSOR AS PART OF FCO8. EV300 SYSTEM BOARD WAS REPLACED TO ADDRESS THE SENSOR DRIFT VERIFICATION TEST FAILURE. NEW INFORMATION: THE FAILED PROPORTIONAL VALVE (AECM) AND 3 WAY SOLENOID VALVE WERE RECEIVED AT THE PHILIPS PRODUCT INVESTIGATION LAB FOR FURTHER INVESTIGATION. ERROR CODES WERE NOTED IN THE EVENT LOG. BOX H CODING WAS UPDATED. THE MANUFACTURER'S INVESTIGATION IS ONGOING. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.

Description of Event or Problem · 0

A TRILOGY EV300 WAS SENT TO A THIRD-PARTY SERVICE CENTER FOR EVALUATION. THERE WAS NO HARM OR INJURY REPORTED. THE DEVICE WAS NOT IN PATIENT USE. DURING THE EVALUATION OF THE DEVICE AT THE SERVICE CENTER, THE DEVICE UNIT FAILED PRE-TESTING, UNIT FAILED SYSTEM SETUP TEST (ACTIVE EXHALATION VERIFICATION: S(+) P(+): PILOT: READING FAILED). THE TECHNICIAN RECOMMENDED REPLACING THE TRILOGY EVO 3-WAY SOLENOID, PROPORTIONAL VALVE (AECM) AND OXYGEN BLENDING MODULE (OBM) TO ADDRESS THE ISSUE. THE REPAIRS ARE PENDING THE CUSTOMERS APPROVAL. FCO FOLLOW-UP REPAIR TO BE HANDLED BY CARROT MEDICAL. A SUPPLEMENT REPORT WILL BE FILED IF NEW INFORMATION BECOMES AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
136208 TRILOGY EV300, USA VENTILATOR, CONTINUOUS, FACILITY USE CBK RESPIRONICS, INC. DS2200X11B 00606959052017

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown